Abstracts tagged "SLE and family studies"

Abstract Number: 2659 • 2018 ACR/ARHP Annual Meeting
Clinical Features, Damage Accrual and Survival in Patients with Familial Systemic Lupus Erythematosus (SLE): Data from a Multiethnic, Multinational Latin American Lupus Cohort
Rosana Quintana^1,2, Guillermo J. Pons-Estel^3,4, Karen Roberts¹, Mónica Sacnun⁵, Rosa Maria Serrano², Romina Nieto¹, Silvana Conti¹, Viviana Gervasoni¹, Luis J. Catoggio⁶, Enrique R Soriano⁷, Marina Scolnik⁷, Mercedes Garcia⁸, Alejandro Alvarellos⁹, Verónica Saurit¹⁰, Guillermo Berbotto¹¹, Emilia Sato¹², Lilian Costallat¹³, Eduardo Borba¹⁴, Eloisa Bonfa¹⁵, Ricardo M. Xavier¹⁶, Ana Carolina de Oliveira e Silva¹⁷, JF Molina¹⁸, Antonio Iglesias-Gamarra¹⁹, Marlene Guibert-Toledano²⁰, Gil A. Reyes²⁰, Loreto Massardo²¹, Oscar J Neira²², Mario H Cardiel²³, Leonor Barile²⁴, Mary Carmen Amigo²⁵, Luis H. Silveira²⁶, Ignacio Garcia de la Torre²⁷, Eduardo Acevedo-Vasquez²⁸, Manuel Ugarte-Gil²⁹, Jose Alfaro-Lozano³⁰, Ines Segami³¹, Rosa Chacón-Díaz³², Maria H Esteva Spinetti³³, Jose A Gómez-Puerta³⁴, Graciela S. Alarcón³⁵ and Bernardo A Pons-Estel², ¹Hospital Provincial de Rosario, Rosario, Argentina, ²Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Rosario, Argentina, ³Rheumatology, Hospital Provincial de Rosario, Rosario, Argentina, ⁴Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario. Argentina, Rosario, Argentina, ⁵Rheumatology Section, Hospital Provincial de Rosario, Rosario, Argentina, ⁶Rheumatology Unit, Internal Medicine Service. Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ⁷Rheumatology Unit, Internal Medicine Service. Hospital Italiano Buenos Aires. Argentina, Buenos Aires, Argentina, ⁸Rheumatology, HIGA General San Martin La Plata, La Plata, Argentina, ⁹Rheumatology, Rheumatology Unit, Hospital Privado Universitario de Córdoba, Cordoba, Argentina, ¹⁰Hospital Privado Centro Médico de Córdoba, Cordoba, Argentina, ¹¹Hospital Escuela Eva Perón, Granadero Baigorria, Argentina, Granadero Baigorria, Argentina, ¹²Rheumatology Division, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, ¹³Universidade Estadual da Campinas, Campinas, Brazil, ¹⁴Faculdade de Medicina, Hospital das Clínicas. Universidade de São Paulo, São Paulo, Brazil, ¹⁵Rheumatology Division, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil, ¹⁶Universidade Federal do Rio Grande do Sul Porto Alegre, Rio Grande do Sul, Brazil, ¹⁷Faculdade de Medicina, Universidade Federal de Goias, Goiania, Brazil, ¹⁸Reumalab, Medellín, Colombia, ¹⁹Clinical Development, Nordic Bioscience, Herlev, Denmark, ²⁰Centro de Investigaciones Médico-Quirúrgicas (CIMEQ), Havana, Cuba, ²¹GLADEL, Santiago, Chile, ²²Hospital del Salvador, Facultad de Medicina, Universidad de Chile, Santiago, Chile, ²³Centro de Investigación Clínica de Morelia, Morelia, Mexico, ²⁴Hospital Ángeles del Pedregal, Mexico, Mexico, ²⁵Rheumatology, Centro Medico ABC, Mexico, Mexico, ²⁶Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City DF, Mexico, ²⁷Hospital General de Occidente, Guadalajara, Mexico, ²⁸Hospital Guillermo Almenara Irigoyen. EsSalud, Lima, Peru, ²⁹Rheumatology, Universidad Científica del Sur, Lima, Peru, ³⁰Rheumatology, Hospital Guillermo Almenara Irigoyen. EsSalud, Lima, Peru, ³¹Hospital Edgardo Rebagliati Martins. EsSalud, Lima, Peru, ³²Servicio de Reumatología, Hospital Universitario de Caracas, Centro Nacional de Enfermedades Reumáticas, Caracas, Venezuela, ³³Hospital Central de San Cristóbal, San Cristobal, Venezuela (Bolivarian Republic of), ³⁴Rheumatology Department, Hospital Clínic, Barcelona, Spain, ³⁵Universidad Peruana Cayetano Heredia, Lima, Peru
Background/Purpose: GLADEL (Grupo Latino Americano De Estudio de Lupus) has previously shown that a 14.1% of its patients have relatives with an autoimmune disease (1).…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].